Psoriasis in the context of comorbidity: focus for hypertension

Purpose. Compare the frequency of occurrence of comorbid pathologies in patients with psoriasis and concomitant hypertension and patients with psoriasis without hypertension, evaluate the severity of psoriasis in patients with concomitant hypertension. Material and methods. The study was attended by 120 patients with psoriasis, divided into 2 groups: 1st (n=60) – patients with psoriasis and hypertension; 2nd (n=60) – patients with psoriasis without hypertension. The study included the analysis of the stories of the disease, the collection of complaints, the anamnesis of the disease, the anamnesis of life, the physical examination, the measurement of blood pressure, the calculation of the prevalence index and the severity of psoriasis (PASI). Results. In patients with psoriasis and concomitant hypertension, the course of the underlying disease took place in a more severe form with a high PASI index. The predominance of exudative forms of the disease, the progressive stage with damage to the scalp, trunk, upper and lower extremities, was noted, and in 43.3% of patients and involving the skin of the face in the pathological process. The number of related diseases and the percentage of patients with polymorbid pathology in a group of patients with psoriasis and hypertension were significantly greater. In this group of patients, a longer stay in the hospital was also noted. Conclusion. In patients with psoriasis, the concomitant hypertension contributes to a more severe course of the skin process, increase the comorbid load, increase polymorbidity and lengthen the temporary disability, thereby worsening the quality of life of patients.